• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立并验证用于预测肾乳头状细胞癌患者肾切除术后疾病特异性生存的列线图。

Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.

机构信息

Department of Urology, Medical University of Vienna, Vienna, Austria.

出版信息

J Urol. 2010 Jul;184(1):53-8. doi: 10.1016/j.juro.2010.03.026. Epub 2010 May 15.

DOI:10.1016/j.juro.2010.03.026
PMID:20478577
Abstract

PURPOSE

We developed and externally validated a prognostic nomogram specifically for papillary renal cell carcinoma.

MATERIALS AND METHODS

We retrospectively studied 435 patients who underwent radical or partial nephrectomy for papillary renal cell carcinoma at 3 institutions. Slides were reviewed by 1 uropathologist per institution. We constructed a nomogram predicting 5-year disease specific survival as a graphic representation of significant variables on multivariate Cox proportional hazards regression analysis using data on 258 patients from 2 of the 3 institutions. Nomogram discrimination and calibration were assessed by bootstrapping to obtain relatively unbiased estimates. External validation was done in 177 patients from a third institution.

RESULTS

At a median 50.8-month followup 77 papillary renal cell carcinoma related deaths had occurred. In the multivariate Cox proportional hazards model incidental detection, T classification, M classification, vascular invasion and tumor necrosis extent were retained as independent prognostic factors of disease specific survival and formed the basis of the nomogram. The nomogram predicted well with a 93.6% bootstrapped corrected concordance index and showed good calibration. External independent validation revealed 94.2% predictive accuracy.

CONCLUSIONS

We developed a highly accurate tool specifically for papillary renal cell carcinoma using basic clinical and pathological information to predict disease specific survival. This tool should be helpful to identify papillary renal cell carcinoma with aggressive clinical behavior and may contribute to the ability to individualize postoperative surveillance and therapy.

摘要

目的

我们开发并外部验证了一个专门针对乳头状肾细胞癌的预后列线图。

材料和方法

我们回顾性研究了 3 家机构的 435 例接受根治性或部分肾切除术的乳头状肾细胞癌患者。每家机构的 1 位泌尿病理学家对切片进行了复查。我们使用来自 3 家机构中的 2 家机构的 258 例患者的数据,通过多变量 Cox 比例风险回归分析构建了一个预测 5 年疾病特异性生存的列线图,作为显著变量的图形表示。通过自举法评估列线图的区分度和校准度,以获得相对无偏估计。在第 3 家机构的 177 例患者中进行了外部验证。

结果

在中位随访 50.8 个月时,77 例乳头状肾细胞癌相关死亡。在多变量 Cox 比例风险模型中,偶然发现、T 分类、M 分类、血管侵犯和肿瘤坏死程度被保留为疾病特异性生存的独立预后因素,并构成了列线图的基础。该列线图预测效果良好,bootstrap 校正后的一致性指数为 93.6%,且校准效果良好。外部独立验证显示预测准确率为 94.2%。

结论

我们使用基本的临床和病理信息为乳头状肾细胞癌开发了一个高度准确的工具,用于预测疾病特异性生存。该工具有助于识别具有侵袭性行为的乳头状肾细胞癌,并可能有助于实现个体化术后监测和治疗。

相似文献

1
Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.建立并验证用于预测肾乳头状细胞癌患者肾切除术后疾病特异性生存的列线图。
J Urol. 2010 Jul;184(1):53-8. doi: 10.1016/j.juro.2010.03.026. Epub 2010 May 15.
2
Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.基于TNM分类的肾细胞癌术前预后列线图(概率表)。
J Urol. 2009 Feb;181(2):480-5; discussion 485. doi: 10.1016/j.juro.2008.10.017. Epub 2008 Dec 19.
3
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.局限性透明细胞肾细胞癌的分子特征预测肾切除术后无病生存期
Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):894-900. doi: 10.1158/1055-9965.EPI-08-0786. Epub 2009 Feb 24.
4
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.一种预测传统透明细胞肾细胞癌患者复发的术后预后列线图。
J Urol. 2005 Jan;173(1):48-51. doi: 10.1097/01.ju.0000148261.19532.2c.
5
Conditional survival predictions after nephrectomy for renal cell carcinoma.肾细胞癌肾切除术后的条件生存预测。
J Urol. 2009 Dec;182(6):2607-12. doi: 10.1016/j.juro.2009.08.084. Epub 2009 Oct 17.
6
Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.中国人群肾切除术后非转移性肾细胞癌当前预后模型的验证:一项15年单中心经验
Int J Urol. 2009 Mar;16(3):268-73. doi: 10.1111/j.1442-2042.2008.02229.x. Epub 2008 Dec 14.
7
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.适用于行部分肾切除术的直径7厘米及以下实性强化肾肿瘤的术前预后列线图。
J Urol. 2007 Aug;178(2):429-34. doi: 10.1016/j.juro.2007.03.106. Epub 2007 Jun 11.
8
A postoperative prognostic nomogram for renal cell carcinoma.一种用于肾细胞癌的术后预后列线图。
J Urol. 2001 Jul;166(1):63-7.
9
External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.梅奥诊所肾癌特异性生存评分在日本透明细胞肾细胞癌系列中的外部验证
J Urol. 2008 Oct;180(4):1290-5; discussion 1295-6. doi: 10.1016/j.juro.2008.06.014. Epub 2008 Aug 15.
10
Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.pT3a期透明细胞肾细胞癌中的肾窦脂肪浸润影响无淋巴结受累或远处转移患者的预后。
J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048. Epub 2009 Mar 14.

引用本文的文献

1
Are We Accurately Predicting Mortality in Renal Cancer? A Systematic Review of Prognostic Models.我们是否准确预测了肾癌的死亡率?预后模型的系统评价。
J Clin Med. 2025 Aug 19;14(16):5851. doi: 10.3390/jcm14165851.
2
Development and validation of prognostic nomograms for adult with papillary renal cell carcinoma: A retrospective study.开发和验证成人肾乳头状细胞癌预后列线图:一项回顾性研究。
Clinics (Sao Paulo). 2024 May 7;79:100374. doi: 10.1016/j.clinsp.2024.100374. eCollection 2024.
3
A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
一种基于人群的研究:预测肾细胞癌患者肾切除术后总生存的新型列线图和风险分类系统。
Front Public Health. 2022 Oct 5;10:989566. doi: 10.3389/fpubh.2022.989566. eCollection 2022.
4
Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations.肾细胞肿瘤的诊断和预后评估:德国 S3 指南建议。
World J Urol. 2022 Oct;40(10):2373-2379. doi: 10.1007/s00345-022-03972-x. Epub 2022 Mar 16.
5
Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.乳头状肾细胞癌:单机构 199 例研究分析其分类、临床病理和分子特征以及治疗结果。
Mod Pathol. 2022 Jun;35(6):825-835. doi: 10.1038/s41379-021-00990-9. Epub 2021 Dec 23.
6
Whether histologic subtyping affect the oncological outcomes of patients with papillary renal cell carcinoma: evidence from a systematic review and meta-analysis.组织学亚型是否影响乳头状肾细胞癌患者的肿瘤学结局:一项系统评价和荟萃分析的证据
Transl Androl Urol. 2021 Aug;10(8):3255-3266. doi: 10.21037/tau-21-329.
7
The first competing risk survival nomogram in patients with papillary renal cell carcinoma.首个用于预测乳头状肾细胞癌患者的竞争风险生存诺莫图。
Sci Rep. 2021 Jun 4;11(1):11835. doi: 10.1038/s41598-021-91217-z.
8
Prognostic models in papillary renal cell carcinoma.乳头状肾细胞癌的预后模型
Ann Transl Med. 2020 Nov;8(21):1334. doi: 10.21037/atm-20-3750.
9
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.基于 ASSURE 前瞻性临床试验队列的非转移性乳头状肾细胞癌术后疾病复发预测的 VENUSS 预后模型:开发与评估。
BMC Med. 2019 Oct 3;17(1):182. doi: 10.1186/s12916-019-1419-1.
10
Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery.术前中性粒细胞与淋巴细胞比值对非转移性乳头状肾细胞癌患者根治性手术后的预测价值。
Cancer Manag Res. 2019 Aug 7;11:7515-7524. doi: 10.2147/CMAR.S211727. eCollection 2019.